12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Onconetix (ONCO) saw a 161.5% rise, while Processa Pharma (PCSA) increased by 98.04%. Acutus Medical (AFIB) and Vera Therapeutics (VERA) also saw substantial gains. Conversely, Redhill Biopharma (RDHL) and Nuwellis (NUWE) were among the notable losers, with declines of 47.6% and 15.2%, respectively. Humana (HUM) also declined by 12.06% after releasing Q4 earnings.
January 25, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acutus Medical stock increased by 49.27% to $0.33, with a market cap of $9.7 million.
The stock's significant gain could indicate a positive development for the company, potentially leading to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Onconetix stock rose sharply by 161.5% to $0.39, with a market cap of $8.5 million.
The significant stock price increase suggests positive investor sentiment or reaction to company-specific news, which could lead to continued short-term momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Processa Pharma shares soared by 98.04% to $4.06, with a market cap of $5.0 million.
The dramatic rise in stock price could attract more attention to the stock, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Vera Therapeutics shares increased by 39.04% to $23.66, with a market cap of $1.0 billion.
The substantial increase in stock price could reflect investor confidence and may lead to continued short-term growth.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Humana stock declined by 12.06% to $353.89 following the release of Q4 earnings, with a market cap of $43.5 billion.
The post-earnings decline suggests a negative market reaction to the Q4 results, which could lead to further short-term pressure on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Nuwellis shares fell 15.2% to $0.46, with a market cap of $2.6 million.
The decline in stock price may continue in the short term if the negative sentiment persists.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Redhill Biopharma stock decreased by 47.6% to $0.57, with a market cap of $11.1 million.
The significant drop in stock price could be due to negative investor sentiment or disappointing company news, likely leading to further short-term downside.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100